Table of Contents
Miss Information
NZDSOS
Historical Knowledge Suppressed: Cancer Treatment and Parasite Treatment
Recently a two page CIA document declassified in 2011, “Biochemical Resemblance Between Endoparasites and Malignant Tumors”, has made headline news. It reveals research from as early as 1938 demonstrating similar metabolic pathways between endoparasites (that live inside host organisms) and malignant tumours, naming two compounds found to be effective against both.
Epidemiologist Nicolas Hulscher articulates the 50-year setback in cancer treatment research resulting from this decades-long information suppression. The cost is the health and lives of many millions, concurrent with intergenerational financial hardship to families in direct correlation with increased corporate profits.
Cancer and Parasites Are Not the Same Thing
Dr Paul Marik’s 2024 publication Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer reviews the published literature on this subject. Importantly, he writes:
Although a number of antiparasitic drugs including ivermectin, mebendazole and niclosamide have proven anti-cancer effects it is important to recognize that cancer is NOT a parasitic disease as has been suggested in the “popular press” and by misguided clinicians. There is no evidence that cancer is caused by or related to any parasitic disease. These drugs act via specific biochemical pathways specific to the cancer cell which are distinct from their anti-parasitic mechanisms of action.
Evidence of Ongoing Medical Crimes
Classifying such potentially lifesaving information as a risk to national defense appears to be an early example of medical censorship protecting pharmaceutical industry profits, which intensified so aggressively in 2020. Thousands of doctors in New Zealand, Australia, the UK, Canada, the USA and beyond, now face public punishment should their actions threaten profit margins. Learn more at the World Council For Health’s webinar series, Punished for Protecting Patients (Part 1 and Part 2). We have written extensively about the origins of global censorship through corporatised centralisation of regulatory authorities, for example here, here and here.
Mechanisms of Action
Over 100 studies now demonstrate at least 20 mechanisms of action which probably make the Covid-19 injections one of the largest carcinogenic exposures in history. We have also written about these multiple mechanisms, for example here, here and here.
In the August 2025 publication of the Journal of Independent Medicine, Dr Paul Marik and Dr Justus Hope wrote:
The incidence of cancers has increased exponentially worldwide since the universal Covid-19 vaccination program began at the end of 2020. These cancers tend to present at an advanced stage, progress rapidly, and occur in younger patients. Additionally, some patients previously in remission have been reported to develop uncontrolled cancer relapses shortly after receiving a Covid-19 vaccination (usually a booster). The temporal association between these cancers and Covid-19 vaccination is undeniable. These observations have given rise to the term “turbo-cancers.”
It is an unlikely coincidence that in December 2023 Pfizer acquired Seagen Inc, “a global biotechnology company that discovers, develops and commercializes transformative cancer medicines.” Total purchase cost was US$43 billion for a company with an annual revenue of $2 billion in 2022. This infers insider trading by a company who knew that cancer was about to become highly lucrative business.
The Burgeoning Revolution in Cancer Treatment
Despite horrific levels of censorship being foisted upon scientific and medical communities, a medical revolution is skyrocketing thanks to the gallant efforts of defiant, competent and ethical trailblazers. The most astonishing reports to date have come from immunologist/oncologist Dr William Makis, whose personal story embodies the backbone required against reprehensible medical crimes being normalised in healthcare systems at the cost of human health and life.
On 7 April 2026 a preprint study, Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort was published with extremely promising results. The researchers enrolled 197 patients with diverse clinical profiles, a median duration since diagnosis of 1.2 years, and almost 40 per cent of whom had active disease progression at study initiation. Ivermectin and mebendazole were added to existing treatments, which included 68.9 per cent on conventional therapies (surgery, chemotherapy and radiotherapy). After six months, 32.8 per cent of study participants reported no current evidence of disease; 15.6 per cent reported disease regression; 36.1 per cent reported stabilised disease; and 15.6 per cent reported disease progression. Minimal side effects requiring minor dose adjustments were reported by 25.4 per cent.
While these findings offer a compelling clinical signal for therapeutic benefit from these anti-parasitic medications, the authors acknowledge a number of study design limitations and argue for “Urgent prospective, randomized, placebo-controlled clinical trials” to validate the results and optimise treatment doses.
Dr Joseph Ladapo, Surgeon General for the state of Florida, announced in October 2025 that his government have committed US$60 million for research into the use of repurposed antiparasitic drugs in cancer treatment. This appears to be in partnership with Dr Makis who spoke with journalist Kim Iversen on the subject in February 2025.
There are over 300 peer reviewed studies that have been published with ivermectin and cancer. Looking at the mechanisms of action … It’s acting on molecular pathways inside the cells, pathways that affect proliferation of cells … It can act on mechanisms of cancer metastasising for example … It goes after cancer stem cells … notoriously difficult to kill. In fact they may be the reason why … the majority of chemotherapy is palliative … Yet ivermectin is able to identify those cells, recognise that those cancer cells are different from normal cells and is able to kill them or inhibit them … This is a drug that’s been used around the world. Four billion doses given. Fifteen times safer than aspirin; 750 times safer than remdesivir. And 17,000 times safer than Covid vaccines.
From the ashes of destruction, a medical revolution is emerging, shining light into the darkness and bringing hope in the midst of despair. Cancer is only one of the vaccine harms being experienced by populations and this is only one of the areas in which cutting edge science is transforming medicine outside of the multi-billion dollar corporate model. We will continue to provide updates as research progresses.
This article was originally published by New Zealand Doctors Speaking Out With Science.
